头颈部癌肿瘤及转移淋巴结检测的红外荧光引导手术
本文综述术中近红外荧光引导手术技术在头颈部癌恶性组织及前哨淋巴结临床检测中的应用,以panitumumab-IRDye800为主要候选示踪剂,并讨论当前应用、局限性与未来方向。
要点
- 近红外荧光引导手术用于头颈部癌术中恶性组织与前哨淋巴结检测。
- panitumumab-IRDye800是当前研究中的主要候选靶向示踪剂。
核心结论
- 综述指出近红外荧光引导手术技术用于头颈部癌恶性组织及前哨淋巴结的临床检测,panitumumab-IRDye800为当前研究的主要候选示踪剂。
研究设计与样本
- 综述,检索范围与纳入文献数原文未报告,聚焦头颈部癌术中近红外荧光引导手术的临床应用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
In patients with head and neck cancer (HNC), surgical removal of cancerous tissue presents the best overall survival rate. However, failure to obtain negative margins during resection has remained a steady concern over the past 3 decades. The need for improved tumor removal and margin assessment presents an ongoing concern for the field. While near-infrared agents have long been used in imaging, investigation of these agents for use in HNC imaging has dramatically expanded in the past decade. Targeted tracers for use in primary and metastatic lymph node detection are of particular interest, with panitumumab-IRDye800 as a major candidate in current studies. This review aims to provide an overview of intraoperative near-infrared fluorescence-guided surgery techniques used in the clinical detection of malignant tissue and sentinel lymph nodes in HNC, highlighting current applications, limitations, and future directions for use of this technology within the field. Keywords: Molecular Imaging-Cancer, Fluorescence © RSNA, 2024.
引用
- White HW, Naveed AB, Campbell BR, et al. Infrared Fluorescence-guided Surgery for Tumor and Metastatic Lymph Node Detection in Head and Neck Cancer. Radiol Imaging Cancer. 2024. PMID: 38940689. doi:10.1148/rycan.230178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。